Updated: 24 May 2026

Coffee and Sports Performance: Caffeine, Dosage and Timing

By expertcafe.be editorial team · Published 24 May 2026 · Reading time: 10 min

Mechanism of Action

The sports science community has traced a clear research journey on caffeine from early stimulant studies in the 1970s through the landmark ergogenic classifications of the 1990s and the decisive regulatory pivot by WADA in 2004. The central mechanism is adenosine receptor antagonism. Adenosine is a nucleoside that accumulates progressively during exercise, generating fatigue by binding to ADORA2A receptors (the A2A subtype most relevant to ergogenic effects) and ADORA1 receptors in the central nervous system. Caffeine, whose molecular structure closely resembles adenosine, competes for these binding sites without activating them, thereby blocking the fatigue signal.

Beyond the central nervous system, caffeine exerts peripheral effects: increased mobilisation of free fatty acids through enhanced lipolysis, potentiation of muscular contraction via action on calcium channels in the sarcoplasmic reticulum, and stimulation of catecholamine release (adrenaline and noradrenaline). Together these mechanisms explain why caffeine's benefits extend well beyond simple reductions in perceived exertion.

The hepatic enzyme CYP1A2 (cytochrome P450 1A2) handles the primary metabolic clearance of caffeine. The rs762551 polymorphism of the CYP1A2 gene distinguishes two principal phenotypes: fast metabolisers (CC genotype), who clear caffeine more rapidly, and slow metabolisers (CA or AA genotypes), who experience a significantly extended plasma half-life. For fast metabolisers, half-life ranges from 3 to 5 hours; for slow metabolisers, it may reach 7 hours or more. This genetic variation accounts for much of the individual variability observed in caffeine response and supports a personalised approach to dosing strategy.

The AIS (Australian Institute of Sport, Australia) classification of caffeine in Group A represents the institutional culmination of decades of research. Group A is reserved for supplements with strong evidence of benefit and low risk when used as directed. The 2004 WADA decision to delist caffeine from prohibited substances removed the regulatory ambiguity that had complicated athlete planning for years. Today, the question for competitive athletes is not whether caffeine works, but how to optimise its use for a specific discipline, body weight, and genetic profile.

Dosage by Body Weight

The ISSN recommends a dosage range of 3 to 6 mg of caffeine per kilogram of body weight. The optimal dose offering the best benefit-to-risk ratio sits between 3 and 4 mg/kg. The table below converts these ranges into milligrams and specialty coffee equivalents.

Methodological note: a 20 cl specialty espresso typically contains 60 to 80 mg of caffeine; a 300 ml filter brew contains 120 to 160 mg. These figures vary according to origin, roast level and extraction method. Decaffeinated coffee is not caffeine-free: it retains 2 to 5 percent of the original caffeine content, amounting to 2 to 6 mg per 20 cl cup, which is insufficient to produce meaningful ergogenic effects at normal serving sizes.

Timing Protocol

Timing is as determinant as dosage in caffeine ergogenics. Standard pharmacokinetic data places the plasma Tmax at 30 to 60 minutes after oral ingestion. Consuming caffeine 45 to 60 minutes before exercise onset ensures that plasma concentration reaches its plateau at the start of the effort. The ergogenic effect persists for 2 to 4 hours beyond that peak, covering the majority of endurance events and standard training sessions.

The plasma half-life of 3 to 7 hours has important practical consequences for recovery. Caffeine consumed in the late afternoon (for example at 17:00) will remain at significant plasma concentrations well into the evening, potentially disrupting sleep quality. For athletes whose nocturnal recovery determines training adaptation, this trade-off between acute performance gain and recovery quality merits careful consideration. Evening training sessions may justify alternative timing strategies or temporary tolerance management.

Differences by Sport Type

Analysis of Cochrane meta-analyses (2010, 2016 and 2020 editions) reveals a consistent hierarchy of caffeine benefits across exercise types. Aerobic endurance sports (cycling, long-distance running, triathlon, open-water swimming) show the strongest and most consistent evidence: average performance improvement of 3 to 4 percent and a 12 percent reduction in fatigue resistance. The data from competitive cycling is particularly robust, with time-trial performances serving as a reproducible outcome measure across dozens of controlled studies.

Team sports such as football, rugby, and basketball present positive but more variable data. The intermittent nature of these efforts and the tactical and technical components dilute the contribution of pure physiological fitness, making performance effects harder to isolate. Sprint performance, reaction time, and repeated sprint ability each show modest improvements in well-controlled studies.

For strength and power disciplines (weightlifting, sprinting, resistance training), evidence is more limited and less consistent. Some studies demonstrate improvements in maximal power output and repetitions to failure; others find no significant effect. CYP1A2 genetic variation and high individual specificity play a larger role in these disciplines than in endurance sport, making population-level predictions less reliable.

Tolerance and Washout

Caffeine tolerance develops rapidly: 3 to 5 days of regular consumption at normal levels (two or more cups daily) is sufficient to significantly reduce the ergogenic effect. The underlying mechanism is adenosine receptor upregulation in response to chronic blockade: the brain compensates by increasing the density of available receptors, requiring progressively higher doses to achieve the same effect.

The washout strategy involves eliminating or drastically reducing caffeine intake for 5 to 7 days before a major competition. This period restores adenosine receptor sensitivity and allows recovery of the full ergogenic effect on race day. The first 48 hours of withdrawal commonly involve headache and reduced training performance: these are transient effects that also serve as indirect evidence of caffeine's pharmacological efficacy. Athletes experienced with washout protocols typically report that the competitive day performance benefit justifies the temporary training disruption.

Practical Preparation with Specialty Coffee

Specialty coffee provides a meaningful advantage for precision dosing because origin and roast profiles are documented and consistent. Arabica varietals used in specialty production typically contain 1.2 to 1.5 percent caffeine by dry weight, compared to approximately 2.7 percent in robusta. An athlete following a precise protocol benefits from sourcing specialty arabica, which provides more predictable caffeine content per gram of ground coffee. Measuring coffee by weight rather than volume eliminates a major source of dosing variability.

Extraction method has little effect on total caffeine yield relative to the dose of coffee used: caffeine is highly soluble and extracted efficiently across all methods including espresso, filter, and AeroPress. The primary variable is concentration per unit volume. A 40 ml espresso is far more concentrated than a 300 ml filter brew, but the filter may deliver more total caffeine if brewed with a larger coffee dose. For athletes with sensitive stomachs before exercise, a longer, more dilute filter brew offers the same total caffeine at a lower concentration, often reducing the risk of gastrointestinal distress.

Safety and Adverse Effects

Doses above 6 mg/kg substantially increase adverse event risk: tremors, tachycardia, anxiety and gastrointestinal distress. These effects are dose-dependent and more pronounced in slow metabolisers (CA or AA genotypes of CYP1A2). The established ISSN ceiling exists for sound pharmacological reasons and pursuit of performance gain does not justify exceeding it.

The dehydration concern associated with caffeine consumption warrants factual clarification. At moderate doses of 3 to 6 mg/kg, caffeine does not cause clinically significant dehydration. Data from the Institute of Medicine (IOM, United States) confirm that coffee contributes positively to daily fluid intake. The mild diuretic effect of caffeine at ergogenic doses is offset by the fluid volume of the coffee itself. Athletes have no physiological basis for reducing hydration strategy in response to pre-exercise coffee consumption.

Frequently Asked Questions

← Back to guides